Silence Therapeutics

-$0.48 (-4.64%) As of 5:16 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLN and other ETFs, options, and stocks.

About SLN

Silence Therapeutics Plc engages in the discovery, delivery and development of ribonucleic acid (RNA) therapeutics. It develops medicines by harnessing the body's natural mechanism of RNA interference within its cells.

CEO
Craig A. Tooman
Employees
—
Headquarters
London, Greater London
Founded
1994

SLN Key Statistics

Market cap
295.39M
Price-Earnings ratio
—
Dividend yield
—
Average volume
12.68K
High today
$9.96
Low today
$8.92
Open price
$9.60
Volume
2.63K
52 Week high
$35.00
52 Week low
$8.21

SLN Earnings

-$0.14
-$0.09
-$0.05
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
— per share
Actual
Expected Aug 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure